Results 121 to 130 of about 734,729 (308)

Center for Surveillance, Epidemiology, and Laboratory Services Division of Laboratory Systems strategic framework 2019-2022 : excellent laboratories, outstanding health

open access: yes
The Centers for Disease Control and Prevention\u2019s (CDC) Division of Laboratory Systems (DLS) works to advance quality and safety systems, informatics and data science, and training and workforce development.

core  

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Recent advances in the detection technologies for balanced chromosomal rearrangements

open access: yesFrontiers in Genetics
Balanced chromosomal rearrangements (BCRs) refer to a type of chromosomal structural variations without chromosomal gains or losses. BCR carriers may experience fertility issues, including a higher risk of infertility, recurrent miscarriages, or having ...
Meng Gao   +5 more
doaj   +1 more source

CDC INFECTIOUS DISEASES LABORATORY TEST DIRECTORY : 2024, Version 17.1

open access: yes
This document was created under Center for Laboratory Systems and Response (CLSR). The printed version of CDC's Infectious Diseases Laboratory Test Directory contains information that is current as of January 19, 2024. All information contained herein is

core  

Self-assessment checklist for good testing practices [PDF]

open access: yes
The following self-assessment checklist emphasizes recommended practices for physicians, nurses, medical assistants, pharmacists, and others who perform patient testing under a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver.

core  

Mycobacterial cell division arrest and smooth‐to‐rough envelope transition using CRISPRi‐mediated genetic repression systems

open access: yesFEBS Open Bio, EarlyView.
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point   +7 more
wiley   +1 more source

Applicability of mitotic figure counting by deep learning: a development and pan‐cancer validation study

open access: yesFEBS Open Bio, EarlyView.
In this study, we developed a deep learning method for mitotic figure counting in H&E‐stained whole‐slide images and evaluated its prognostic impact in 13 external validation cohorts from seven different cancer types. Patients with more mitotic figures per mm2 had significantly worse patient outcome in all the studied cancer types except colorectal ...
Joakim Kalsnes   +32 more
wiley   +1 more source

Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) [PDF]

open access: yes
Updated Aug. 11, 2020Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2.

core   +2 more sources

Provider performed microscopy procedures : a focus on quality practices [PDF]

open access: yes
Health care providers use laboratory test results to diagnose disease, determine prognosis, and monitor a patient\u2019s treatment or health status. Current practice shows an increased trend for medical decisions based on tests performed at the point of ...

core  

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

open access: yesFEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy